The latest leukaemia news
Oncotarget published “Inhibitory effects of Tomivosertib in acute myeloid leukemia” which reported that the authors…
Chronic lymphocytic leukaemia (CLL) is the most common leukaemia in the Western world. New research…
The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell…
Scientists from the UCLA Jonsson Comprehensive Cancer Center, USA, have identified a key protein, transcription…
The investigational therapeutic ficlatuzumab in combination with chemotherapy showed signs of clinical efficacy in patients…
For the first time, Princess Margaret researchers (Canada) have mapped out where and how leukaemia…
A research collaboration based in Kumamoto University (Japan) has shown that lysine-specific demethylase 1 (LSD1),…
Bristol Myers Squibb announced that the European Commission (EC) has granted full marketing authorisation for…
Two recent collaborative publications by Colorado University Cancer Center (USA) members provide insights into how…
Leukaemia is a group of blood cancers that affects thousands of people worldwide. However, with…